Lightnews — Scholar-powered news

Reposted by Tian Zhang, MD

OncoDaily @oncodaily.bsky.social · Aug 6

Great Editorial Led by Nicolas Sayegh on Subsets of Prostate Cancer - Tian Zhang
@tiansterzhangmd.bsky.social

oncodaily.com/insight/nico...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ProstateCancer

Tian Zhang: Great Editorial Led by Nicolas Sayegh on Subsets of Prostate Cancer - OncoDaily

Tian Zhang: Great Editorial Led by Nicolas Sayegh on Subsets of Prostate Cancer /

oncodaily.com

1 7

Reposted by Tian Zhang, MD

VJOncology @vjoncology.bsky.social · Jul 22

🎥Results from PDIGREE: ipi + nivo in mccRCC shows consistent safety & early CRs in a diverse U.S. population

@tiansterzhangmd.bsky.social shares insights from #ASCO25

➡️https://buff.ly/o2oUojf⬅️

@ASCO #kcsm #UroOnc #UroSoMe #CTSM #TrialUpdate #ImmunoOnc

Ipilimumab and nivolumab induction in PDIGREE: step 1 findings in mccRCC - VJOncology

Tian Zhang, MD, UT Southwestern Medical Center, Dallas, TX, describes results from step 1 of the PDIGREE trial (NCT03793166), which...

buff.ly

1 1

Tian Zhang, MD @tiansterzhangmd.bsky.social · Jul 19

#ShahneenSandhu on collaborative efforts with industry partners - how do we maximize time & effort to make industry supported IITs and large phase 3 trials for clinical development. @anzuptrials.bsky.social #ANZUP25

1 4

Tian Zhang, MD @tiansterzhangmd.bsky.social · Jul 19

@profiand.bsky.social with key insights to large trial and grant funding in Australia — trial impact, equity in diverse populations, cost effectiveness, patient advocate/consumer involvement, and feasibility @anzuptrials.bsky.social #ANZUP25

1 2

Tian Zhang, MD @tiansterzhangmd.bsky.social · Jul 19

Great kickoff to clinical trials workshop #ANZUP25 — #MelissaLeMesurier w patient perspective and #ChrisGianacas biostats on collaborative efforts for clinical trials. Same global themes for clinical trial development. @anzuptrials.bsky.social @craiggedye.bsky.social @profiand.bsky.social

2 4

Tian Zhang, MD @tiansterzhangmd.bsky.social · Jul 19

Pleasure to highlight your work with #UroToday @ravimadan.bsky.social - as we all consider how best to treat PSMA avid disease.

Ravi Madan @ravimadan.bsky.social · Jul 18

Do #PSMA+ findings in #BCR #ProstateCancer require immediate treatment?

NO based on emerging data @theNCI

Appreciate @tiansterzhangmd.bsky.social & #Urotoday for the opportunity to discuss

Ongoing trial of PSMA scans in BCR is still enrolling shorturl.at/36nGQ

www.urotoday.com/categories-m...

PSMA PET in Biochemical Recurrence: When to Treat vs When to Wait - Ravi Madan

Tian Zhang interviews Ravi Madan about a prospective study monitoring PSMA PET-positive biochemically recurrent prostate cancer patients. The trial enrolls patients with PSA > 0.5 and negative convent...

www.urotoday.com

1 5

Tian Zhang, MD @tiansterzhangmd.bsky.social · Jun 24

Proud of our #UTSWcancer clinical research teams displaying our cancer center’s ongoing work in clinical trials @aacicancer.bsky.social #CRI25 meeting today! Clinical trials are essential to improving outcomes for our patients with cancer - here to network & learn best practices!

2

Reposted by Tian Zhang, MD

Megan Ranney MD MPH @meganranney.bsky.social · Jun 15

I categorically refuse to accept either of these as normal or routine.

www.nytimes.com/2025/06/14/u...

Like School Shootings, Political Violence Is Becoming Almost Routine

www.nytimes.com

28 170 870

Tian Zhang, MD @tiansterzhangmd.bsky.social · Jun 3

See our #Urotoday recording with David Wise on this promising trial in #prostatecancer reported at #ASCO25!

urldefense.com/v3/__https:/...

2

Reposted by Tian Zhang, MD

American Society of Clinical Oncology @ascocancer.bsky.social · Jun 1

New from #ASCO25: Final results of CheckMate-214 show that nivo + ipi continues to improve OS compared with sunitinib for previously untreated advanced RCC: dailynews.ascopubs.org/do/checkmate... #ASCODailyNews @mskcancercenter.bsky.social @tiansterzhangmd.bsky.social

1 3

Tian Zhang, MD @tiansterzhangmd.bsky.social · May 30

The connections built within ASCO transcend our daily institutions, across borders, across disease types. We are in this together and we will come out stronger for it — we must, for our patients. See y’all soon @ascocancer.bsky.social #ASCO25 #FIN

1

Tian Zhang, MD @tiansterzhangmd.bsky.social · May 30

Am looking forward to seeing & meeting our colleagues from around the world, adding our knowledge gained, and contributing in my role @utswcancer to our cancer research fields. @ascocancer.bsky.social #ASCO25

1 1

Tian Zhang, MD @tiansterzhangmd.bsky.social · May 30

We celebrate early career investigators who will make new discoveries to push the field. Even as federal funding decreases, now more than ever we depend on foundations like @ConquerCancerFd @kidneycancer @kccure for this new generation of minds hard at work. @ASCO #ASCO25

1

Tian Zhang, MD @tiansterzhangmd.bsky.social · May 30

The global community comes together for 5 days #ASCO25 to share our work and our advances for our patients. Cancer knows no boundaries and knowledge will empower each of us in daily work ahead. @ASCO

1 1

Tian Zhang, MD @tiansterzhangmd.bsky.social · May 30

That’s what we all want with this brief time on earth — More time to be productive. More time to see the world. More time with loved ones. @ASCO #ASCO25

1

Tian Zhang, MD @tiansterzhangmd.bsky.social · May 30

At the center of next few days @asco #Asco25: our patients. And — if we face our humanity, ourselves —as we age & deal w/ cancer. Nothing harder in my clinic than telling a patient “there are no more treatment options”. Every trial gives hope & every new drug gives more time. 2/n

1

Tian Zhang, MD @tiansterzhangmd.bsky.social · May 30

Traveling w/ mixed emotions to @asco #asco25 this yr. Celebrating science & the yrs of dedication, work, & patient contributions to cancer clinical trials. But science itself is under attack — defunding of preclinical discovery work will end up slowing our clinical advances. 1/n

1 2 2

Tian Zhang, MD @tiansterzhangmd.bsky.social · May 19

Our hearts go out to the Biden family. Metastatic prostate cancer is common but hard. They will face many treatment decisions ahead. apple.news/Ai-QLq9onRNW...

Biden diagnosed with ‘aggressive form’ of prostate cancer — CNN

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer, according to a statement from his personal office Sunday, and it has spread to his bones.

apple.news

1

Reposted by Tian Zhang, MD

OncoDaily @oncodaily.bsky.social · May 5

Women in RCC Negotiations Spotlight at IKCSEU25 - Tian Zhang
@tiansterzhangmd.bsky.social
@drnataliagandur.bsky.social
@kidney-cancer.bsky.social

oncodaily.com/blog/tian-zh...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IKCSEU25 #RCC #IKCS25 #WomenInRCC

Tian Zhang: Women in RCC Negotiations Spotlight at IKCSEU25 - OncoDaily

Tian Zhang: Women in RCC Negotiations Spotlight at IKCSEU25 / cancer, Cora Sternberg, IKCS25, IKCSEU25, Kidney Cancer Association, Laurence Albiges, Lisa

oncodaily.com

1 7

Tian Zhang, MD @tiansterzhangmd.bsky.social · Apr 28

Plenary session with @MarcelaMaus @MGHCancerCenter on future CAR-T cells — setting vision toward personalized, patient centered approaches to find the right CARTs. #AACR25 @oncoalert.bsky.social @theaacr.bsky.social

1 1

Reposted by Tian Zhang, MD

Sid Sadler @sadlersnaps.bsky.social · Apr 22

Hey all my #Cansky and especially #Kidneycancer folks, check out this awesome episode from @lauraesfeller.bsky.social and Judy Nicholson Foundation featuring @tiansterzhangmd.bsky.social. Fantastic episode👏🏻👏🏻.

youtu.be/25TXzH5suio?...

Real Talk on Renal Cancer: Dr. Tian Zhang (Episode 14)

YouTube video by Judy Nicholson Kidney Cancer Foundation

youtu.be

1 4

Tian Zhang, MD @tiansterzhangmd.bsky.social · Apr 4

A great start to #UTChrisWood25 - localized RCC discussions from diagnosis (ccRCC score) & novel tracers to treatment of surgery, SBRT, & ablation. #IvanPedrosa #ChadTang #JoseKaram #IsamuTachibana #mohamedabdelsalam & interactive panel discussion!

Reposted by Tian Zhang, MD

OncoDaily @oncodaily.bsky.social · Apr 4

Best practices for second line treatment in Metastatic Urothelial Carcinoma - @tiansterzhangmd.bsky.social .bsky.social

oncodaily.com/url/267046

#GUOnc #UrothelialCarcinoma #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer

Tian Zhang: Best practices for second line treatment in Metastatic Urothelial Carcinoma - OncoDaily

Tian Zhang: Best practices for second line treatment in Metastatic Urothelial Carcinoma / Astellas, atezolizumab, Aveluma, Avelumab, Biomarker selection,

oncodaily.com

1 7

Tian Zhang, MD @tiansterzhangmd.bsky.social · Feb 20

Also welcome, glad you’re here on Bluesky 🤗

Tian Zhang, MD @tiansterzhangmd.bsky.social · Feb 20

Have added you to my bladder-kidney cancer starter pack! Likely @ravimadan.bsky.social would add you to the prostate cancer one too!

1 2